Works matching IS 08876924 AND DT 2009 AND VI 23 AND IP 9

Results: 19

AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1598, doi. 10.1038/leu.2009.104
By:
- Jiao, B.;
- Wu, C.-F.;
- Liang, Y.;
- Chen, H.-M.;
- Xiong, S.-M.;
- Chen, B.;
- Shi, J.-Y.;
- Wang, Y.-Y.;
- Wang, J.-H.;
- Chen, Y.;
- Li, J.-M.;
- Gu, L.-J.;
- Tang, J.-Y.;
- Shen, Z.-X.;
- Gu, B.-W.;
- Zhao, W.-L.;
- Chen, Z.;
- Chen, S.-J.
Publication type:
Article
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value.
Published in:
2009
By:
- Hochhaus, A.;
- Müller, M. C.;
- Radich, J.;
- Branford, S.;
- Kantarjian, H. M.;
- Hanfstein, B.;
- Rousselot, P.;
- Kim, D.-W.;
- Lipton, J. H.;
- Bleickardt, E.;
- Lambert, A.;
- Hughes, T. P.;
- Müller, M C
Publication type:
journal article
The role of monocytes-macrophages in vasculogenesis in multiple myeloma.
Published in:
2009
By:
- Ribatti, D.;
- Vacca, A.
Publication type:
Editorial
The gatekeeper mutation T315I confers resistance against small molecules by increasing or restoring the ABL-kinase activity accompanied by aberrant transphosphorylation of endogenous BCR, even in loss-of-function mutants of BCR/ABL.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1614, doi. 10.1038/leu.2009.69
By:
- Mian, A. A.;
- Schüll, M.;
- Zhao, Z.;
- Oancea, C.;
- Hundertmark, A.;
- Beissert, T.;
- Ottmann, O. G.;
- Ruthardt, M.
Publication type:
Article
WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1634, doi. 10.1038/leu.2009.70
By:
- Weber, G.;
- Karbach, J.;
- Kuçi, S.;
- Kreyenberg, H.;
- Willasch, A.;
- Koscielniak, E.;
- Tonn, T.;
- Klingebiel, T.;
- Wels, W. S.;
- Jäger, E.;
- Bader, P.
Publication type:
Article
BCR–ABL promotes neutrophil differentiation in the chronic phase of chronic myeloid leukemia by downregulating c-Jun expression.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1622, doi. 10.1038/leu.2009.74
By:
- Kobayashi, S.;
- Kimura, F.;
- Ikeda, T.;
- Osawa, Y.;
- Torikai, H.;
- Kobayashi, A.;
- Sato, K.;
- Motoyoshi, K.
Publication type:
Article
Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1643, doi. 10.1038/leu.2009.76
By:
- Bebawy, M.;
- Combes, V.;
- Lee, E.;
- Jaiswal, R.;
- Gong, J.;
- Bonhoure, A.;
- Grau, G. E. R.
Publication type:
Article
Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1650, doi. 10.1038/leu.2009.78
By:
- Qian, Z.;
- Mao, L.;
- Fernald, A. A.;
- Yu, H.;
- Luo, R.;
- Jiang, Y.;
- Anastasi, J.;
- Valk, P. J.;
- Delwel, R.;
- Le Beau, M. M.
Publication type:
Article
Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics.
Published in:
2009
By:
- Heinrichs, S.;
- Kulkarni, R. V.;
- Bueso-Ramos, C. E.;
- Levine, R. L.;
- Loh, M. L.;
- Li, C.;
- Neuberg, D.;
- Kornblau, S. M.;
- Issa, J.-P.;
- Gilliland, D. G.;
- Garcia-Manero, G.;
- Kantarjian, H. M.;
- Estey, E. H.;
- Look, A. T.
Publication type:
journal article
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1679, doi. 10.1038/leu.2009.83
By:
- Perrone, G.;
- Hideshima, T.;
- Ikeda, H.;
- Okawa, Y.;
- Calabrese, E.;
- Gorgun, G.;
- Santo, L.;
- Cirstea, D.;
- Raje, N.;
- Chauhan, D.;
- Baccarani, M.;
- Cavo, M.;
- Anderson, K. C.
Publication type:
Article
Involvement of mast cells by the malignant process in patients with Philadelphia chromosome negative myeloproliferative neoplasms.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1577, doi. 10.1038/leu.2009.85
By:
- Wang, J.;
- Ishii, T.;
- Zhang, W.;
- Sozer, S.;
- Dai, Y.;
- Mascarenhas, J.;
- Najfeld, V.;
- Zhao, Z. J.;
- Hoffman, R.;
- Wisch, N.;
- Xu, M.
Publication type:
Article
Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1658, doi. 10.1038/leu.2009.86
By:
- Valencia, A.;
- Román-Gómez, J.;
- Cervera, J.;
- Such, E.;
- Barragán, E.;
- Bolufer, P.;
- Moscardó, F.;
- Sanz, G. F.;
- Sanz, M. A.
Publication type:
Article
Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia.
Published in:
2009
By:
- Cortes, J. E.;
- Egorin, M. J.;
- Guilhot, F.;
- Molimard, M.;
- Mahon, F.-X.
Publication type:
journal article
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1545, doi. 10.1038/leu.2009.89
By:
- Dimopoulos, M.;
- Terpos, E.;
- Comenzo, R. L.;
- Tosi, P.;
- Beksac, M.;
- Sezer, O.;
- Siegel, D.;
- Lokhorst, H.;
- Kumar, S.;
- Rajkumar, S. V.;
- Niesvizky, R.;
- Moulopoulos, L. A.;
- Durie, B. G. M.
Publication type:
Article
STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma.
Published in:
2009
By:
- Coppo, P.;
- Gouilleux-Gruart, V.;
- Huang, Y.;
- Bouhlal, H.;
- Bouamar, H.;
- Bouchet, S.;
- Perrot, C.;
- Vieillard, V.;
- Dartigues, P.;
- Gaulard, P.;
- Agbalika, F.;
- Douay, L.;
- Lassoued, K.;
- Gorin, N.-C.
Publication type:
journal article
Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.
Published in:
2009
By:
- Renouf, B.;
- Hollville, É;
- Pujals, A.;
- Tétaud, C.;
- Garibal, J.;
- Wiels, J.;
- Hollville, E;
- Tétaud, C
Publication type:
journal article
A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1564, doi. 10.1038/leu.2009.94
By:
- Ikezoe, T.;
- Yang, J.;
- Nishioka, C.;
- Takezaki, Y.;
- Tasaka, T.;
- Togitani, K.;
- Koeffler, H. P.;
- Yokoyama, A.
Publication type:
Article
Efficacy of dasatinib in conjunction with α-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia.
Published in:
2009
By:
- Visani, G.;
- Piccaluga, P.;
- Malagola, M.;
- Isidori, A.
Publication type:
Case Study
Monoclonal antibodies against IREM-1: potential for targeted therapy of AML.
Published in:
Leukemia (08876924), 2009, v. 23, n. 9, p. 1587, doi. 10.1038/leu.2009.99
By:
- Korver, W.;
- Zhao, X.;
- Singh, S.;
- Pardoux, C.;
- Zhao, J.;
- Guzman, M. L.;
- Sen, S.;
- Yonkovich, S.;
- Liu, S.;
- Zhan, X.;
- Tomasevic, N.;
- Zhou, C.;
- Gros, D.;
- Jordan, C. T.;
- Gotlib, J.;
- Hsi, E. D.;
- Abo, A.
Publication type:
Article